PT1420801E - Utilização de fucanos no tratamento de adesões, artrite e psoríase - Google Patents
Utilização de fucanos no tratamento de adesões, artrite e psoríase Download PDFInfo
- Publication number
- PT1420801E PT1420801E PT02758008T PT02758008T PT1420801E PT 1420801 E PT1420801 E PT 1420801E PT 02758008 T PT02758008 T PT 02758008T PT 02758008 T PT02758008 T PT 02758008T PT 1420801 E PT1420801 E PT 1420801E
- Authority
- PT
- Portugal
- Prior art keywords
- fucans
- psoriasis
- arthritis
- adhesions
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/042—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31536201P | 2001-08-29 | 2001-08-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1420801E true PT1420801E (pt) | 2008-01-17 |
Family
ID=23224048
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT02758008T PT1420801E (pt) | 2001-08-29 | 2002-08-29 | Utilização de fucanos no tratamento de adesões, artrite e psoríase |
Country Status (16)
Country | Link |
---|---|
US (3) | US6812220B2 (pt) |
EP (1) | EP1420801B1 (pt) |
JP (2) | JP4758063B2 (pt) |
KR (2) | KR20090019926A (pt) |
CN (2) | CN1319540C (pt) |
AT (1) | ATE376835T1 (pt) |
AU (1) | AU2002325113B2 (pt) |
CA (1) | CA2458853C (pt) |
DE (1) | DE60223262T2 (pt) |
DK (1) | DK1420801T3 (pt) |
ES (1) | ES2295386T3 (pt) |
HK (1) | HK1066482A1 (pt) |
MX (1) | MXPA04001876A (pt) |
NZ (2) | NZ547609A (pt) |
PT (1) | PT1420801E (pt) |
WO (1) | WO2003018033A1 (pt) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6632456B1 (en) * | 1993-06-24 | 2003-10-14 | Astrazeneca Ab | Compositions for inhalation |
US7595378B2 (en) | 2001-06-13 | 2009-09-29 | Genmab A/S | Human monoclonal antibodies to epidermal growth factor receptor (EGFR) |
DK1539157T3 (da) * | 2002-09-18 | 2013-10-07 | Univ Pennsylvania | Fremgangsmåde til hæmning af choroidal neovaskularisering |
US7465766B2 (en) | 2004-01-08 | 2008-12-16 | The Cleveland Clinic Foundation | Hydroxyphenyl cross-linked macromolecular network and applications thereof |
US8138265B2 (en) | 2003-01-10 | 2012-03-20 | The Cleveland Clinic Foundation | Hydroxyphenyl cross-linked macromolecular network and applications thereof |
US8137688B2 (en) | 2003-01-10 | 2012-03-20 | The Cleveland Clinic Foundation | Hydroxyphenyl cross-linked macromolecular network and applications thereof |
US6982298B2 (en) | 2003-01-10 | 2006-01-03 | The Cleveland Clinic Foundation | Hydroxyphenyl cross-linked macromolecular network and applications thereof |
WO2004078210A1 (ja) | 2003-03-06 | 2004-09-16 | Takashi Muramatsu | 開腹手術後の癒着の予防剤 |
BRPI0418384A (pt) * | 2003-05-30 | 2007-06-26 | Arc Pharmaceuticals Inc | composições farmacêuticas e métodos referentes à inibição de adesões fibrosas utilizando diversos agentes |
WO2005089800A1 (ja) * | 2004-03-17 | 2005-09-29 | Locomogene, Inc. | hsHRD3を含む医薬組成物 |
WO2006010066A2 (en) * | 2004-07-09 | 2006-01-26 | The Cleveland Clinic Foundation | Hydroxyphenyl cross-linked macromolecular network and applications thereof |
WO2006032144A1 (en) * | 2004-09-23 | 2006-03-30 | Arc Pharmaceuticals, Inc. | Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions or inflammatory disease using fucans from various echinoderm sources |
US8663639B2 (en) | 2005-02-09 | 2014-03-04 | Santen Pharmaceutical Co., Ltd. | Formulations for treating ocular diseases and conditions |
AU2006213673A1 (en) | 2005-02-09 | 2006-08-17 | Santen Pharmaceutical Co., Ltd. | Formulations for ocular treatment |
EA013214B1 (ru) * | 2005-02-16 | 2010-04-30 | ЭмДи БАЙОАЛЬФА КО., ЛТД. | Применение фармацевтической композиции для лечения диабета, метаболического синдрома, нейродегенеративных заболеваний и ожирения |
US20060210692A1 (en) * | 2005-03-18 | 2006-09-21 | Mower Thomas E | Baby food composition |
US20060210515A1 (en) * | 2005-03-18 | 2006-09-21 | Mower Thomas E | Hair growth formula |
US20060210496A1 (en) * | 2005-03-18 | 2006-09-21 | Mower Thomas E | Compositions for skin protection from ultraviolet damage |
US20060210688A1 (en) * | 2005-03-18 | 2006-09-21 | Mower Thomas E | Dehydrated sports drink powder |
US7749545B2 (en) * | 2005-03-18 | 2010-07-06 | Sakura Properties, Llc | Fucoidan compositions and methods for dietary and nutritional supplements |
US7776365B2 (en) * | 2005-03-18 | 2010-08-17 | Sakura Properties, Llc | Article with skin protecting and moisturizing compound |
US20060210697A1 (en) * | 2005-03-18 | 2006-09-21 | Mower Thomas E | Infant formula composition |
US20070020358A1 (en) * | 2005-03-18 | 2007-01-25 | Mower Thomas E | Sports drink concentrate |
US20060210514A1 (en) * | 2005-03-18 | 2006-09-21 | Mower Thomas E | Skin protection and moisturizing compositions and method of making the same |
US7666448B2 (en) * | 2005-03-18 | 2010-02-23 | Sakura Properties, Llc | Skin cleansing article |
ATE492275T1 (de) | 2005-04-15 | 2011-01-15 | Einstein Coll Med | Vitamin k zur vorbeugung und behandlung von hautausschlag infolge einer anti-egfr-therapie |
US20070003669A1 (en) * | 2005-06-02 | 2007-01-04 | Troy Kearl | Fucoidan delivery system |
US8426381B2 (en) * | 2005-09-09 | 2013-04-23 | Lucas Meyer Cosmetics Canada Inc. | Polysaccharides compositions comprising fucans and galactans and their use to reduce extravasation and inflammation |
JP5528708B2 (ja) | 2006-02-09 | 2014-06-25 | 参天製薬株式会社 | 安定な製剤ならびにそれらを調製および使用する方法 |
FR2897538B1 (fr) | 2006-02-23 | 2008-05-02 | Univ Paris Descartes | Utilisation de fucanes a des fins de greffe, d'ingenierie et de regeneration osseuses |
KR101520408B1 (ko) | 2006-03-23 | 2015-05-14 | 산텐 세이야꾸 가부시키가이샤 | 혈관 투과성-관련 질환 또는 상태를 위한 제형 및 방법 |
JP4814677B2 (ja) * | 2006-03-31 | 2011-11-16 | 株式会社荏原製作所 | 基板保持装置および研磨装置 |
WO2008003317A1 (en) | 2006-07-03 | 2008-01-10 | Genmab A/S | Prevention of rash in patients undergoing anti-egfr therapy |
EP2249891B1 (en) | 2008-02-13 | 2016-05-25 | The Cleveland Clinic Foundation | Molecular enhancement of extracellular matrix and methods of use |
US8815953B2 (en) | 2008-03-13 | 2014-08-26 | Spectrum Pharmaceuticals, Inc. | Formulations of vitamin K analogs for topical use |
WO2009135029A2 (en) | 2008-04-30 | 2009-11-05 | The Cleveland Clinic Foundation | Compositions and methods to treat urinary incontinence |
WO2010109736A1 (ja) | 2009-03-25 | 2010-09-30 | 国立大学法人鳥取大学 | 軟骨生成促進剤および軟骨損傷由来疾病の予防治療剤 |
JO3676B1 (ar) | 2009-07-27 | 2020-08-27 | Arc Medical Devices Inc | مركبات صيدلانية تضم فوكانات معدلة وطرق تتعلق بها |
KR101528265B1 (ko) * | 2010-04-16 | 2015-06-11 | 코웨이 주식회사 | 베타-라파콘을 유효성분으로 포함하는 주름개선용 화장료 조성물 |
CA2838793C (en) * | 2011-07-19 | 2019-08-06 | Baxter International Inc. | Resorption enhancers as additives to improve the oral formulation of non-anticoagulant sulfated polysaccharides |
JP2018510905A (ja) * | 2015-02-16 | 2018-04-19 | エグザンシャル | 皮膚障害の予防又は治療のための組成物 |
PL3448421T3 (pl) * | 2016-04-29 | 2022-03-28 | The Board Of Trustees Of The Leland Stanford Junior University | Sposoby i kompozycje do zapobiegania i leczenia zrostów chirurgicznych |
EP3829600A4 (en) * | 2018-07-27 | 2022-06-15 | Arc Medical Devices, Inc. | LOW ENDOTOXIN FUCCO COMPOSITIONS, SYSTEMS AND METHODS |
CN111617030B (zh) * | 2020-05-22 | 2021-09-07 | 广东药科大学 | 壳寡糖口服液及其在制备减肥药物中的应用 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3971848A (en) * | 1970-12-21 | 1976-07-27 | Kimitsu Chemical Laboratory Co. Ltd. | Lubricating composition for mucosa or epidermis |
EP0293826A3 (en) | 1987-06-02 | 1989-05-10 | Stichting REGA V.Z.W. | Therapeutic and prophylactic application of sulfated polysaccharides against aids |
JPS6431707A (en) | 1987-07-28 | 1989-02-02 | Nikko Chemicals | Dermal agent for external use |
JPH0714850B2 (ja) | 1987-09-29 | 1995-02-22 | 喜郎 板谷 | 化粧料 |
JPH01313433A (ja) | 1988-06-13 | 1989-12-18 | Nippon Koutai Kenkyusho:Kk | 抗hiv剤 |
JP2853165B2 (ja) * | 1989-05-29 | 1999-02-03 | 味の素株式会社 | 体組織癒着防止膜 |
FR2648463B1 (fr) * | 1989-06-14 | 1993-01-22 | Inst Fs Rech Expl Mer | Polysaccharides sulfates, agent anticoagulant et agent anticomplementaire obtenus a partir de fucanes d'algues brunes et leur procede d'obtention |
US6096722A (en) * | 1990-08-14 | 2000-08-01 | Isis Pharmaceuticals Inc. | Antisense modulation of cell adhesion molecule expression and treatment of cell adhesion molecule-associated diseases |
US5318890A (en) * | 1991-05-06 | 1994-06-07 | The Regents Of The University Of California | Assays for inhibitors of leukocyte adhesion |
US5605938A (en) * | 1991-05-31 | 1997-02-25 | Gliatech, Inc. | Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate |
JP3403496B2 (ja) * | 1993-09-24 | 2003-05-06 | 株式会社ヤクルト本社 | 抗潰瘍剤およびヘリコバクター・ピロリの定着阻害剤 |
JP3545789B2 (ja) * | 1993-09-30 | 2004-07-21 | 味の素ファルマ株式会社 | 腹腔内癒着防止剤 |
FR2772618B1 (fr) * | 1997-12-18 | 2000-02-18 | Ifremer | Utilisation de fucane comme regulateur de la reconstruction des tissus conjonctifs |
EP1117835A4 (en) * | 1998-10-02 | 2005-03-09 | Genzyme Corp | adhesion prevention |
JP4267106B2 (ja) * | 1998-10-15 | 2009-05-27 | 株式会社クラレ | 癒着防止用材料 |
JP2001052309A (ja) | 1999-08-06 | 2001-02-23 | Alps Electric Co Ltd | 薄膜磁気ヘッドおよびその製造方法 |
SE0001631D0 (sv) * | 2000-05-04 | 2000-05-04 | Sahltech Ab | New use |
-
2002
- 2002-08-28 US US10/232,850 patent/US6812220B2/en not_active Expired - Lifetime
- 2002-08-29 CN CNB028166930A patent/CN1319540C/zh not_active Expired - Fee Related
- 2002-08-29 WO PCT/CA2002/001337 patent/WO2003018033A1/en active Application Filing
- 2002-08-29 DK DK02758008T patent/DK1420801T3/da active
- 2002-08-29 KR KR1020097002751A patent/KR20090019926A/ko not_active Application Discontinuation
- 2002-08-29 ES ES02758008T patent/ES2295386T3/es not_active Expired - Lifetime
- 2002-08-29 AT AT02758008T patent/ATE376835T1/de active
- 2002-08-29 KR KR1020047003089A patent/KR100910246B1/ko active IP Right Grant
- 2002-08-29 EP EP02758008A patent/EP1420801B1/en not_active Expired - Lifetime
- 2002-08-29 NZ NZ547609A patent/NZ547609A/en not_active IP Right Cessation
- 2002-08-29 DE DE60223262T patent/DE60223262T2/de not_active Expired - Lifetime
- 2002-08-29 PT PT02758008T patent/PT1420801E/pt unknown
- 2002-08-29 CA CA2458853A patent/CA2458853C/en not_active Expired - Lifetime
- 2002-08-29 AU AU2002325113A patent/AU2002325113B2/en not_active Ceased
- 2002-08-29 MX MXPA04001876A patent/MXPA04001876A/es active IP Right Grant
- 2002-08-29 JP JP2003522551A patent/JP4758063B2/ja not_active Expired - Lifetime
- 2002-08-29 CN CNA200710096370XA patent/CN101028283A/zh active Pending
- 2002-08-29 NZ NZ532015A patent/NZ532015A/en not_active IP Right Cessation
-
2004
- 2004-09-13 US US10/940,413 patent/US20050074496A1/en not_active Abandoned
- 2004-10-05 US US10/958,759 patent/US7163930B2/en active Active - Reinstated
- 2004-12-01 HK HK04109493A patent/HK1066482A1/xx not_active IP Right Cessation
-
2009
- 2009-07-21 JP JP2009170270A patent/JP2009280597A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
KR100910246B1 (ko) | 2009-07-31 |
WO2003018033A1 (en) | 2003-03-06 |
KR20040032992A (ko) | 2004-04-17 |
EP1420801B1 (en) | 2007-10-31 |
ATE376835T1 (de) | 2007-11-15 |
JP2009280597A (ja) | 2009-12-03 |
DK1420801T3 (da) | 2008-03-03 |
AU2002325113B2 (en) | 2006-10-26 |
KR20090019926A (ko) | 2009-02-25 |
ES2295386T3 (es) | 2008-04-16 |
CN101028283A (zh) | 2007-09-05 |
CN1547478A (zh) | 2004-11-17 |
CA2458853C (en) | 2010-10-19 |
US7163930B2 (en) | 2007-01-16 |
US6812220B2 (en) | 2004-11-02 |
DE60223262D1 (de) | 2007-12-13 |
DE60223262T2 (de) | 2008-08-14 |
CA2458853A1 (en) | 2003-03-06 |
HK1066482A1 (en) | 2005-03-24 |
CN1319540C (zh) | 2007-06-06 |
JP2005508893A (ja) | 2005-04-07 |
MXPA04001876A (es) | 2004-06-15 |
EP1420801A1 (en) | 2004-05-26 |
US20050119216A1 (en) | 2005-06-02 |
JP4758063B2 (ja) | 2011-08-24 |
US20030064958A1 (en) | 2003-04-03 |
NZ547609A (en) | 2008-07-31 |
US20050074496A1 (en) | 2005-04-07 |
NZ532015A (en) | 2006-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1420801E (pt) | Utilização de fucanos no tratamento de adesões, artrite e psoríase | |
WO2004052280A3 (en) | Anti-angiogenic compounds and their use in cancer treatment | |
GEP20063805B (en) | Alkyne-Arylnaphthyridin-4-one as Phosphodiesterase-4 Inhibitors | |
IL172773A0 (en) | Formulations for the treatment of arhritis conditions | |
MY137757A (en) | Therapeutic treatment | |
MXPA05010819A (es) | Uso de antagonistas de opioide perifericos, especialmente metilnaltrexona para tratar sindrome de intestino irritable. | |
WO2004030627A3 (en) | Synergistic methods and compositions for treating cancer | |
HUS1300069I1 (hu) | Dextrometorfánt és kinidint tartalmazó gyógyászati készítmények neurológiai rendellenességek kezelésére | |
TW200510416A (en) | P38 inhibitors and methods of use thereof | |
MX349188B (es) | Sns - 595 y metodos para utilizar el mismo. | |
HK1096392A1 (en) | Substituted heterocycles | |
WO2005037323A3 (en) | Use of gro to treat or prevent inflammation | |
TW200509949A (en) | Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents | |
WO2003099266A3 (en) | Acetamides and benzamides that are useful in treating sexual dysfunction | |
IL151692A0 (en) | Polyamine analogues as cytotoxic agents | |
AU2001246600A1 (en) | Use of comt inhibitors as analgesics | |
EP1383516A4 (en) | CO-ADMINISTRATION OF A POLYSACCHARIDE WITH A CHEMOTHERAPEUTIC AGENT FOR THE TREATMENT OF CANCER | |
GEP20053590B (en) | Phenyl Heterocyclyl Ether Derivatives as Serotonin Re-Uptake Inhibitors | |
GB0215526D0 (en) | Anticancer compounds | |
MXPA05011699A (es) | Inhibidores de la bomba de protones para el tratamiento de trastornos del abdomen inferior. | |
WO2002041831A3 (en) | Inositol derivatives for increasing chloride secretion and inhibiting inflammation | |
BR0111785A (pt) | Composições e métodos para tratamento de candidìase | |
PT1303520E (pt) | Compostos terapêuticos e métodos | |
WO2002076930A3 (en) | Substituted diarylureas as stimulators for fas-mediated apoptosis | |
PL367401A1 (en) | Utilization of buprenorphine in urinary incontinence therapy |